Crystal structures of human serum albumin in complex with lysophosphatidylcholine.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
07 11 2023
Historique:
received: 07 07 2023
revised: 04 09 2023
accepted: 14 09 2023
pmc-release: 07 11 2024
medline: 10 11 2023
pubmed: 21 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

Lysophospholipids (lysoPLs) are crucial metabolites involved in various physiological and pathological cellular processes. Understanding their binding interactions, particularly with human serum albumin (HSA), is essential due to their role in regulating lysoPLs-induced cytotoxicity. However, the precise mechanism of lysoPLs binding to HSA remains elusive. In this study, we employed fluorescence quenching and optical interferometry assays to demonstrate direct binding between lysophosphatidylcholine (LPC) and HSA (K

Identifiants

pubmed: 37731243
pii: S0006-3495(23)00584-2
doi: 10.1016/j.bpj.2023.09.007
pmc: PMC10645546
pii:
doi:

Substances chimiques

Serum Albumin, Human ZIF514RVZR
Lysophosphatidylcholines 0
Serum Albumin 0
Myristates 0
Fatty Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4135-4143

Informations de copyright

Copyright © 2023 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Biochim Biophys Acta. 1999 Nov 23;1441(2-3):131-40
pubmed: 10570241
J Protein Chem. 1996 Apr;15(3):265-72
pubmed: 8804574
Biochemistry. 2006 Nov 28;45(47):14021-31
pubmed: 17115697
Biochem J. 1994 Aug 1;301 ( Pt 3):801-6
pubmed: 8053904
Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):130-8
pubmed: 17259079
Atherosclerosis. 2010 Jan;208(1):10-8
pubmed: 19570538
J Mol Biol. 2000 Nov 10;303(5):721-32
pubmed: 11061971
Science. 2019 Oct 18;366(6463):
pubmed: 31624181
Science. 2021 Mar 12;371(6534):
pubmed: 33707237
J Pharm Biomed Anal. 2006 May 3;41(2):393-9
pubmed: 16413740
Prog Lipid Res. 2020 Nov;80:101068
pubmed: 33068601
Hepatology. 2021 Nov;74(5):2848-2862
pubmed: 33772846
Biochem Biophys Res Commun. 2002 Mar 8;291(4):813-9
pubmed: 11866438
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):23-32
pubmed: 12570723
J Mol Biol. 2001 Dec 14;314(5):955-60
pubmed: 11743713
Semin Cell Dev Biol. 2004 Oct;15(5):513-20
pubmed: 15271296
Annu Rev Pathol. 2022 Jan 24;17:459-483
pubmed: 34813354
Biosci Rep. 2016 Jun 03;36(3):
pubmed: 27129297
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1955-7
pubmed: 12393928
FEBS Lett. 1969 Oct 21;5(2):112-114
pubmed: 11947253
Cell Mol Life Sci. 2006 Dec;63(23):2695-701
pubmed: 16988788
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
J Mol Biol. 2005 Oct 14;353(1):38-52
pubmed: 16169013
J Mol Cell Cardiol. 1984 Jul;16(7):605-21
pubmed: 6471108
J Biol Chem. 1984 Mar 25;259(6):3812-7
pubmed: 6706980
Life Sci. 2020 Apr 15;247:117443
pubmed: 32084434
J Biol Chem. 2013 May 31;288(22):15980-7
pubmed: 23592780
J Control Release. 2022 Aug;348:115-126
pubmed: 35643382
J Mol Biol. 2008 Aug 29;381(2):394-406
pubmed: 18602119
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jul;1865(7):158685
pubmed: 32169655
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19078-83
pubmed: 22042856
Int J Biol Macromol. 2022 Sep 1;216:172-178
pubmed: 35788007
J Clin Invest. 1958 Nov;37(11):1504-15
pubmed: 13587659
Biochem J. 2009 Sep 14;423(1):23-30
pubmed: 19601929
Mol Pharmacol. 1976 Nov;12(6):1052-61
pubmed: 1004490
J Mol Biol. 2006 Aug 11;361(2):336-51
pubmed: 16844140
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Methods Enzymol. 2003;374:300-21
pubmed: 14696379
Proteome Sci. 2008 Nov 04;6:31
pubmed: 18983648
Mol Pharmacol. 1975 Nov;11(6):824-32
pubmed: 1207674
J Struct Biol. 2007 Feb;157(2):348-55
pubmed: 17067818
Inflamm Res. 2012 May;61(5):473-83
pubmed: 22252240
J Cell Biol. 2002 Jul 22;158(2):227-33
pubmed: 12119361
J Struct Biol. 2008 Apr;162(1):40-9
pubmed: 18258455
Nat Struct Biol. 1998 Sep;5(9):827-35
pubmed: 9731778
Nature. 1992 Jul 16;358(6383):209-15
pubmed: 1630489
Science. 1989 Jun 9;244(4909):1195-8
pubmed: 2727704

Auteurs

Yu Wang (Y)

College of Chemistry, Fuzhou University, Fuzhou, China; Key Laboratory of Pathogenic Fungi and Mycotoxins of Fujian Province, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.

Zhipu Luo (Z)

Soochow University, Suzhou, China.

Xavier Morelli (X)

CRCM, CNRS, INSERM, Institut Paoli-Calmettes, University Aix-Marseill1715e, Marseille, France.

Peng Xu (P)

College of Biological Science and Engineering, Fuzhou University, Fuzhou, China.

Longguang Jiang (L)

College of Chemistry, Fuzhou University, Fuzhou, China. Electronic address: jianglg@fzu.edu.cn.

Xiaoli Shi (X)

State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China. Electronic address: sxl_sharly@fjirsm.ac.cn.

Mingdong Huang (M)

College of Chemistry, Fuzhou University, Fuzhou, China. Electronic address: hmd_lab@fzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH